Table 1.
Baseline characteristics of study subjects
| HIV-/TB | HIV+/TB | HC | BD | |
| n = 59 | n = 36 | n = 17 | n = 46 | |
| Age (years) | 23 (20–29) | 29 (24–34) | 25 (21–35) | 26 (20–37) |
| Sex | ||||
| Female | 31 | 22 | 12 | 11 |
| Male | 28 | 14 | 5 | 35 |
| BCG vaccination scar (%) | 7 | 8 | 18 | 7 |
| Family member treated for TB (%) | 25 | 36 | 100 | 0 |
| X-ray | n = 53 | n = 33 | ||
| Normal (%) | 0 | 3 | ||
| Minimal TB (%) | 21 | 36 | ||
| Moderately advanced TB (%) | 49 | 49 | ||
| Far advanced TB (%) | 30 | 12* | ||
| Sedimentation rate (mm/h) | 68 (47–80) | 83 (70–98)* | ||
| Body mass index (kg/m2) | 16.3 (15.5–18.4) | 16.4 (14.7–18.1) | ||
| Estimated weight loss (kg) | 5.0 (3.0–8.0) | 6.0 (3.3–9.3) | ||
| Temperature (°C) | 37.7 (37.2–38.3) | 37.9 (37.3–38.5) | ||
| Fever (%) | 90 | 100 | ||
| Fever (weeks) | 8.0 (4.0–12.0) | 8.4 (4.0–12.0) | ||
| Cough (weeks) | 10.0 (4.0–16.0) | 8.0 (4.0–13.0) | ||
| Haemoptysis (%) | 27 | 27 | ||
| Haemoptysis (weeks) | 0.0 (0.0–0.3) | 0.0 (0.0–0.2) |
Data are presented as median and inter quartile range. TB (tuberculosis), HIV (human immunodeficiency virus), HC (household contacts), BD (blood donors), BCG (bacillus Calmette-Guérin), SR (sedimentation rate). * p < 0.05 between HIV-/TB and HIV+/TB patients.